Interpace Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Interpace Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 26% to $40,214,000. The net income raised on $802,000 and profit margin reached 2%. Total operating expenses were $20,232,000.
Profit Margin
| 2014 | 119.93M | -16.07M | -13.4% |
|---|---|---|---|
| 2015 | 9.43M | -11.35M | -120.4% |
| 2016 | 13.08M | -8.33M | -63.68% |
| 2017 | 15.89M | -12.21M | -76.84% |
| 2018 | 21.89M | -12.18M | -55.67% |
| 2019 | 24.07M | -26.63M | -110.63% |
| 2020 | 32.39M | -26.20M | -80.87% |
| 2021 | 41.31M | -14.74M | -35.69% |
| 2022 | 31.83M | -5.86M | -18.42% |
| 2023 | 40.21M | 802K | 1.99% |
IDXG Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 40.21M | 31.83M | 41.31M | 32.39M | 24.07M | 21.89M | 15.89M | 13.08M | 9.43M | 119.93M |
Cost of revenue | 16.31M | 13.60M | 23.36M | 21.67M | 15.88M | 10.19M | 7.35M | 6.64M | 6.91M | 101.39M |
Gross profit | 23.90M | 18.23M | 17.94M | 10.72M | 8.19M | 11.69M | 8.53M | 6.44M | 2.52M | 18.54M |
Operating exp. | ||||||||||
Research and development | 636K | 703K | 1.88M | 2.79M | 2.81M | 2.12M | 1.46M | 1.64M | 2.29M | 255K |
Selling and marketing | 10.23M | 9.12M | 10.06M | 9.25M | 11.11M | 8.42M | 6.56M | 5.46M | 10.35M | 604K |
Total operating expenses | 20.23M | 22.07M | 29.68M | 37.28M | 32.12M | 22.29M | 20.43M | 21.38M | 33.38M | 29.92M |
Operating income | 2.80M | -3.84M | -11.73M | -26.55M | -23.93M | -12.11M | -6.29M | -6.44M | -40.40M | -13.47M |
Other income (expenses), net | -1.67M | -1.99M | -3.67M | -82K | -2.73M | -1.25M | -6.83M | 8.51M | -3.79M | -670K |
Income before tax | 1.12M | -5.83M | -15.41M | -26.14M | -26.66M | -12.18M | -13.13M | -8.57M | -44.20M | -14.14M |
Income tax expense | 17K | 29K | -667K | 53K | -28K | 18K | -395K | -162K | -13.13M | -4.73M |
Net income | 802K | -5.86M | -14.74M | -26.20M | -26.63M | -12.18M | -12.21M | -8.33M | -11.35M | -16.07M |
Earnings per share | ||||||||||
Basic EPS | 0.19 | -1.38 | -3.57 | -6.5 | -7.11 | -4.33 | -7.77 | -45.88 | -73.38 | -107.87 |
Diluted EPS | 0.18 | -1.38 | -3.57 | -6.5 | -7.11 | -4.33 | -7.75 | -45.88 | -73.36 | -107.87 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |